Literature DB >> 28838786

Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct-Acting Antiviral Agents.

George Cholankeril1, Andrew A Li1, Katherine L March2, Eric R Yoo3, Donghee Kim1, Heather Snyder2, Stevan A Gonzalez4, Zobair M Younossi5, Aijaz Ahmed6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28838786     DOI： 10.1016/j.cgh.2017.08.020

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  14 in total

1.  An Advanced Practice Practitioner-Based Program to Reduce 30- and 90-Day Readmissions After Liver Transplantation.

Authors:  Nadim Mahmud; Samantha Halpern; Rebecca Farrell; Kate Ventura; Arwin Thomasson; Heidi Lewis; Kim M Olthoff; Matthew H Levine; Susanna Nazarian; Vandana Khungar
Journal:  Liver Transpl       Date:  2019-04-23       Impact factor: 5.799

2.  Impact of Drug Overdose Deaths on Solid Organ Transplantation in the United States.

Authors:  George Cholankeril; Andrew A Li; Rosann Cholankeril; Alice E Toll; Jeffrey S Glenn; Aijaz Ahmed
Journal:  J Gen Intern Med       Date:  2018-09       Impact factor: 5.128

3.  Functional Status at Liver Transplant Waitlisting Correlates With Greater Odds of Encephalopathy, Ascites, and Spontaneous Bacterial Peritonitis.

Authors:  Patrick McCabe; Grishma Hirode; Robert Wong
Journal:  J Clin Exp Hepatol       Date:  2020-04-27

4.  Alcoholic Liver Disease Replaces Hepatitis C Virus Infection as the Leading Indication for Liver Transplantation in the United States.

Authors:  George Cholankeril; Aijaz Ahmed
Journal:  Clin Gastroenterol Hepatol       Date:  2017-12-01       Impact factor: 11.382

5.  Lower Likelihood of Post-transplant Graft Failure, Death, and Retransplantation in the Era of Direct-Acting Antivirals.

Authors:  Kellie Young; Benny Liu; Taft Bhuket; Robert J Wong
Journal:  J Clin Exp Hepatol       Date:  2020-02-21

Review 6.  Essential updates 2018/2019: Liver transplantation.

Authors:  Masahiro Ohira; Naoki Tanimine; Tsuyoshi Kobayashi; Hideki Ohdan
Journal:  Ann Gastroenterol Surg       Date:  2020-02-25

7.  The Changing Face of Liver Transplantation in the United States: The Effect of HCV Antiviral Eras on Transplantation Trends and Outcomes.

Authors:  Nicholas F Parrish; Irene D Feurer; Lea K Matsuoka; Scott A Rega; Roman Perri; Sophoclis P Alexopoulos
Journal:  Transplant Direct       Date:  2019-02-20

Review 8.  Infectious Complications Following Kidney Transplantation-A Focus on Hepatitis C Infection, Cytomegalovirus Infection and Novel Developments in the Gut Microbiota.

Authors:  Samuel Chan; Nicole M Isbel; Carmel M Hawley; Scott B Campbell; Katrina L Campbell; Mark Morrison; Ross S Francis; E Geoffrey Playford; David W Johnson
Journal:  Medicina (Kaunas)       Date:  2019-10-04       Impact factor: 2.430

9.  Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era.

Authors:  Andrew A Li; George Cholankeril; Xingxing S Cheng; Jane C Tan; Donghee Kim; Alice E Toll; Satheesh Nair; Aijaz Ahmed
Journal:  Diseases       Date:  2018-07-10

10.  Outcomes in the Era of Interferon-Free Direct-Acting Antiviral Therapy After Liver Transplantation in Patients with Hepatitis C Virus and Hepatocellular Carcinoma.

Authors:  Mohamed Saleh Ismail; Islam Mohamed; Efstathia Polychronopoulou; John A Goss; Yong-Fang Kuo; Fasiha Kanwal; Prasun K Jalal
Journal:  J Hepatocell Carcinoma       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.